These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sirtuins--novel therapeutic targets to treat age-associated diseases. Lavu S; Boss O; Elliott PJ; Lambert PD Nat Rev Drug Discov; 2008 Oct; 7(10):841-53. PubMed ID: 18827827 [TBL] [Abstract][Full Text] [Related]
3. The neurobiology of sirtuins and their role in neurodegeneration. Donmez G Trends Pharmacol Sci; 2012 Sep; 33(9):494-501. PubMed ID: 22749331 [TBL] [Abstract][Full Text] [Related]
5. Sirtuins Function as the Modulators in Aging-related Diseases in Common or Respectively. Wang QL; Guo SJ Chin Med J (Engl); 2015 Jun; 128(12):1671-8. PubMed ID: 26063372 [No Abstract] [Full Text] [Related]
6. SIRTUIN 1: regulating the regulator. Zschoernig B; Mahlknecht U Biochem Biophys Res Commun; 2008 Nov; 376(2):251-5. PubMed ID: 18774777 [TBL] [Abstract][Full Text] [Related]
7. Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence. Albani D; Polito L; Forloni G J Alzheimers Dis; 2010; 19(1):11-26. PubMed ID: 20061622 [TBL] [Abstract][Full Text] [Related]
8. Sirtuins, aging, and metabolism. Guarente L Cold Spring Harb Symp Quant Biol; 2011; 76():81-90. PubMed ID: 22114328 [TBL] [Abstract][Full Text] [Related]
9. The Sirtuin family: therapeutic targets to treat diseases of aging. Milne JC; Denu JM Curr Opin Chem Biol; 2008 Feb; 12(1):11-7. PubMed ID: 18282481 [TBL] [Abstract][Full Text] [Related]
10. Sirtuins in aging and disease. Guarente L Cold Spring Harb Symp Quant Biol; 2007; 72():483-8. PubMed ID: 18419308 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of activators and inhibitors of sirtuins. Balcerczyk A; Pirola L Biofactors; 2010; 36(5):383-93. PubMed ID: 20848588 [TBL] [Abstract][Full Text] [Related]
13. Sirtuins in gamete biology and reproductive physiology: emerging roles and therapeutic potential in female and male infertility. Tatone C; Di Emidio G; Barbonetti A; Carta G; Luciano AM; Falone S; Amicarelli F Hum Reprod Update; 2018 May; 24(3):267-289. PubMed ID: 29447380 [TBL] [Abstract][Full Text] [Related]
14. Small Molecules as SIRT Modulators. Bai X; Yao L; Ma X; Xu X Mini Rev Med Chem; 2018; 18(13):1151-1157. PubMed ID: 27334466 [TBL] [Abstract][Full Text] [Related]
15. [Sirtuins--modulation of their activity as a novel therapeutic target]. Kucińska M; Piotrowska H; Murias M Pol Merkur Lekarski; 2010 Mar; 28(165):231-5. PubMed ID: 20815175 [TBL] [Abstract][Full Text] [Related]
16. Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders. Jęśko H; Wencel P; Strosznajder RP; Strosznajder JB Neurochem Res; 2017 Mar; 42(3):876-890. PubMed ID: 27882448 [TBL] [Abstract][Full Text] [Related]
17. After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders. Huber K; Superti-Furga G Bioorg Med Chem; 2011 Jun; 19(12):3616-24. PubMed ID: 21306906 [TBL] [Abstract][Full Text] [Related]
18. Aging and disease: connections to sirtuins. Donmez G; Guarente L Aging Cell; 2010 Apr; 9(2):285-90. PubMed ID: 20409078 [TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of proteins interacting with SIRT1 and SIRT3: implications in the anti-aging and metabolic effects of sirtuins. Law IK; Liu L; Xu A; Lam KS; Vanhoutte PM; Che CM; Leung PT; Wang Y Proteomics; 2009 May; 9(9):2444-56. PubMed ID: 19343720 [TBL] [Abstract][Full Text] [Related]